AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 67(4), 2002, pp. 436-442
Copyright © 2002 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strickland, G.
Right arrow Articles by Fix, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strickland, G.
Right arrow Articles by Fix, A
Related Collections
Right arrow Hepatitis
American Journal of Tropical Medicine and Hygiene, Vol 67, Issue 4, 436-442
Copyright © 2002 by American Society of Tropical Medicine and Hygiene

Research Articles


Role of hepatitis C infection in chronic liver disease in Egypt

GT Strickland, H Elhefni, T Salman, I Waked, M Abdel-Hamid, NN Mikhail, G Esmat, and A Fix

Hepatitis C virus (HCV) is considered the most common etiology of chronic liver disease (CLD) in Egypt, where prevalence of antibodies to HCV (anti-HCV) is approximately 10-fold greater than in the United States and Europe. Reported are results that show the role of HCV in both overt and occult CLD, the risk factors for CLD and for HCV infection, and the relative importance of chronic HCV, hepatitis B, or both in causing hepatic morbidity. Case patients included 237 new outpatients at the National Liver Institute. Controls comprised 212 sex- and age-matched neighbors without liver disease. Case patients were more likely than controls to report a history of blood transfusions, schistosomiasis, or parenteral therapy for schistosomiasis; to have anti-HCV, HCV RNA, hepatitis B surface antigen, and serum alanine aminotransferase (ALT) elevations; and to have abdominal ultrasound findings of cirrhosis, portal hypertension, and splenomegaly. Anti-HCV-positive case patients were more likely than anti-HCV-negative patients to be male, older, and farmers: to have received a blood transfusion or parenteral therapy for schistosomiasis; to have ALT elevations; and to have ultrasound findings of cirrhosis, portal hypertension, and spleen enlargement. Anti-HCV-positive controls were more likely than anti-HCV-negative controls to have received parenteral therapy for schistosomiasis. These data support the belief that HCV is the predominant cause of CLD in Egypt and suggest there is a large underlying reservoir of HCV-caused liver disease.


This article has been cited by other articles:


Home page
 J. Gen. Virol.Home page
M. Abdel-Hamid, M. El-Daly, V. Molnegren, S. El-Kafrawy, S. Abdel-Latif, G. Esmat, G. T. Strickland, C. Loffredo, J. Albert, and A. Widell
Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma
J. Gen. Virol., May 1, 2007; 88(5): 1526 - 1531.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. AL-SHERBINY, A. OSMAN, N. MOHAMED, M. T. SHATA, F. ABDEL-AZIZ, M. ABDEL-HAMID, S. F. ABDELWAHAB, N. MIKHAIL, S. STOSZEK, L. RUGGERI, et al.
EXPOSURE TO HEPATITIS C VIRUS INDUCES CELLULAR IMMUNE RESPONSES WITHOUT DETECTABLE VIREMIA OR SEROCONVERSION
Am J Trop Med Hyg, July 1, 2005; 73(1): 44 - 49.
[Abstract] [Full Text] [PDF]

Home page
 Mol Biol EvolHome page
A. J. Drummond, A. Rambaut, B. Shapiro, and O. G. Pybus
Bayesian Coalescent Inference of Past Population Dynamics from Molecular Sequences
Mol. Biol. Evol., May 1, 2005; 22(5): 1185 - 1192.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society of Tropical Medicine and Hygiene.